Oral antiplatelet agents for the management of acute coronary syndromes: A review for nurses and allied healthcare professionals
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American Association of Nurse Practitioners"
DOI: 10.1002/2327-6924.12438
Abstract: Purpose We review the use of oral antiplatelet (OAP) therapies in acute coronary syndrome (ACS) management for nurse practitioners (NPs), focusing on current guideline recommendations. Data sources Treatment guidelines and clinical articles from PubMed. Conclusions… read more here.
Keywords: clopidogrel; ticagrelor; antiplatelet; management ... See more keywords
Percutaneous coronary intervention with drug‐coated balloon‐only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel concept
Sign Up to like & getrecommendations! Published in 2023 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30558
Abstract: At least 1 month of dual antiplatelet therapy is required after coronary stenting. The aim of this all‐comers retrospective registry study was to assess the efficacy and safety of percutaneous coronary intervention (PCI) using drug‐coated… read more here.
Keywords: percutaneous coronary; coated balloon; coronary intervention; drug coated ... See more keywords
Cost‐effectiveness analysis of 30‐month vs 12‐month dual antiplatelet therapy with clopidogrel and aspirin after drug‐eluting stents in patients with acute coronary syndrome
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Cardiology"
DOI: 10.1002/clc.22756
Abstract: Continuation of dual antiplatelet therapy (DAPT) beyond 1 year reduces late stent thrombosis and ischemic events after drug‐eluting stents (DES) but increases risk of bleeding. We hypothesized that extending DAPT from 12 months to 30… read more here.
Keywords: dapt; antiplatelet; continuation; dapt continuation ... See more keywords
Role of P2Y12 Receptor in Thrombosis.
Sign Up to like & getrecommendations! Published in 2017 at "Advances in experimental medicine and biology"
DOI: 10.1007/5584_2016_123
Abstract: P2Y12 receptor is a 342 amino acid Gi-coupled receptor predominantly expressed on platelets. P2Y12 receptor is physiologically activated by ADP and inhibits adenyl cyclase (AC) to decrease cyclic AMP (cAMP) level, resulting in platelet aggregation.… read more here.
Keywords: antiplatelet; thrombosis; role; receptor ... See more keywords
[Oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation after coronary interventions].
Sign Up to like & getrecommendations! Published in 2019 at "Herz"
DOI: 10.1007/s00059-019-4811-x
Abstract: Dual antiplatelet therapy (DAPT) is the cornerstone of maintenance medication following elective percutaneous coronary intervention and also after acute coronary syndrome (ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, unstable angina pectoris); however, DAPT is not sufficient… read more here.
Keywords: atrial fibrillation; antiplatelet; antiplatelet therapy; therapy ... See more keywords
Safety and efficacy of a pre-treatment antiplatelet regimen of unruptured intracranial aneurysms: a single-center experience
Sign Up to like & getrecommendations! Published in 2020 at "Neuroradiology"
DOI: 10.1007/s00234-020-02387-y
Abstract: Purpose Endovascular treatment of unruptured intracranial aneurysms with stent-assisted coiling or flow diverter stents requires a prophylactic antiplatelet premedication to avoid thrombo-embolic complications. Guidelines for optimal antiplatelet regimens are poorly defined. The aim of this… read more here.
Keywords: antiplatelet; treatment; intracranial aneurysms; morbidity ... See more keywords
Antiplatelet Therapy is Associated with Stent Patency After Iliocaval Venous Stenting
Sign Up to like & getrecommendations! Published in 2018 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-018-2062-5
Abstract: PurposeTo examine the effectiveness of antithrombotic medications to prevent venous stent malfunction for iliocaval occlusive disease.Materials and MethodsA retrospective analysis was performed on 62 patients who underwent technically successful endovascular iliocaval stent placement between May… read more here.
Keywords: patency; antiplatelet; iliocaval venous; venous stenting ... See more keywords
Evaluation and optimization of prescribed concomitant antiplatelet and anticoagulation therapy centrally managed by an anticoagulation management service
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-020-02207-3
Abstract: Patients on long-term anticoagulation combined with antiplatelet therapy have an increased risk of bleeding compared to patients on anticoagulation alone. The aim of this study was to evaluate the appropriateness of antiplatelet therapy in patients… read more here.
Keywords: anticoagulation; risk; long term; antiplatelet ... See more keywords
Comparison on Anticoagulation and Antiplatelet Aggregation Effects of Puerarin with Heparin Sodium and Tirofiban Hydrochloride: An In Vitro Study
Sign Up to like & getrecommendations! Published in 2017 at "Chinese Journal of Integrative Medicine"
DOI: 10.1007/s11655-017-2419-7
Abstract: ObjectiveTo detect the anticoagulation and antiplatelet effects of different concentrations of puerarin, heparin sodium and tirofiban hydrochloride on the blood samples of healthy volunteers by Sonoclot coagulation and platelet function analyzer.MethodsPeripheral blood samples were extracted… read more here.
Keywords: antiplatelet; tirofiban hydrochloride; heparin sodium; puerarin heparin ... See more keywords
Contemporary Antiplatelet Pharmacotherapy in the Management of Acute Coronary Syndromes
Sign Up to like & getrecommendations! Published in 2018 at "Current Treatment Options in Cardiovascular Medicine"
DOI: 10.1007/s11936-018-0603-5
Abstract: Purpose of reviewAntiplatelet therapies are pivotal treatments in the management of acute coronary syndrome (ACS) with or without revascularization. In recent years, the use of P2Y12 antagonists prior to catheterization, so-called pretreatment, has been questioned,… read more here.
Keywords: contemporary antiplatelet; antiplatelet; management acute; acute coronary ... See more keywords
Antiplatelet Medications and Biomarkers of Hemostasis May Explain the Association of Hematoma Appearance and Subsequent Hematoma Expansion After Intracerebral Hemorrhage
Sign Up to like & getrecommendations! Published in 2021 at "Neurocritical Care"
DOI: 10.1007/s12028-021-01369-z
Abstract: To test the hypothesis that appearances of intracranial hematomas on diagnostic computed tomography (CT) are not idiosyncratic and reflect a biologically plausible mechanism, we evaluated the association between hematoma appearance on CT, biomarkers of platelet… read more here.
Keywords: association hematoma; platelet activity; antiplatelet; sign ... See more keywords